fda bpc 157 category 2 compounding 2023 BPC-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank The FDA's Category 2 list

The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like 83% of peptide aware Americans want the FDA to make peptides more accessible AOL FDA's Overreach on Compounded Peptides Undercutting HHS Secretary Robert F. Kennedy Jr.'s recent push to expand access to peptides, FDA career scientists determined there isn't adequate evidence to support any of the ones under consideration for production

SKU: 7199587412 · From chapuisstores.ch